Deciphering the $372 Billion Increase in Life Sciences M&A: Less Deals, Larger Investments
The recent surge in life sciences M&A deals totaling $372 billion has puzzled industry experts and executives alike, with the...
The recent surge in life sciences M&A deals totaling $372 billion has puzzled industry experts and executives alike, with the...
UL Solutions, a safety certification company listed on the NYSE with the ticker symbol ULS, is set to release its...
Deadline to Lead in Securities Fraud Lawsuit Against Kyndryl Holdings, Inc. (KD) is April 13, 2026 - Contact Kaplan Fox...
In November, prior to his appointment as chairman of the regulatory body responsible for overseeing prediction markets, Mike Selig assured...
A recent insider purchase made by Charles Cherington, a 10% owner of the company with the ticker symbol $ERNA, involved...
Saga Communications President and CEO Chris Forgy has taken a temporary medical leave of absence, as announced in an SEC...
Paris, February 17, 2026. Today, Sanofi has made public its submission of the Form 20-F to the U.S. Securities and...
The "NYSE Arca" recently submitted a proposal to the Securities and Exchange Commission regarding a rule change that would potentially...
Investors in the biotech company uniQure N.V. suffered a significant blow when the FDA delayed approval for one of its...
Investor rights law firm Rosen Law Firm is notifying individuals who acquired Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) common stock between...
ements regarding the Company's business, operational, and compliance policies. Specifically, Defendants failed to disclose that Beyond Meat was experiencing deteriorating...
DOOR Investors Get Chance to Take Lead in Masonite International Corporation Stock Fraud Lawsuit Investors in Masonite International Corporation have...